IDiyas

For the Inventor, By the Inventor

Seoul, South Korea

Hyewhon Rhim

USPTO Granted Patents = 11

Average Co-Inventor Count = 6.9

ph-index = 2

Forward Citations = 33(Granted Patents)


Company Filing History:

goldMedal11 out of 2,164 
 
Korea Institute of Science and Technology
 patents

Years Active: 2005-2023

Loading Chart...
11 patents (USPTO):Explore Patents
1. 11668709 - System for monitoring post-translational modification of protein using bio-sensor with gap and manufacturing method for bio-sensor (2023-06-06),
2. 8492384 - Imidazolylalkylcarbonyl derivatives as calcium channel modulators and preparation method thereof (2013-07-23),
3. 8299072 - Pyrazolylmethylamine compounds as calcium channel modulators and preparation method thereof (2012-10-30),
4. 8148402 - Isoindolinone derivatives having inhibitory activity against T-type calcium channel and method for preparation thereof (2012-04-03),
5. 7939672 - Phenylacetate derivatives or pharmaceutically acceptable salts thereof, preparation method thereof and composition for prevention or treatment of diseases induced by activation of T-type calcium ion channel containing the same as an active ingredient (2011-05-10),
6. 7674596 - Transfected cell line and a method using the same for the high throughput screening for inhibitors of the T-type calcium channel alpha-1H (2010-03-09),
7. 7544686 - Piperazinylalkylpyrazole derivatives useful as selective T-type calcium channel blockers and preparation method thereof (2009-06-09),
8. 7319098 - 1,3-dioxoisoindole derivatives having selective antagonism of T-type calcium channel (2008-01-15),
9. 7271260 - 3,4-dihydroquinazoline derivatives as T-type calcium channel blockers and method of preparing the same (2007-09-18),
10. 6984521 - [object Object] (2006-01-10),
11. 6955904 - Gene coding for quinone oxidoreductase of kluyveromyces marxianus and protein expressed therefrom (2005-10-18),

Title: Innovator Spotlight: Hyewhon Rhim Revolutionizing Bio-sensor Technology in Seoul

Introduction: Hyewhon Rhim, a prolific inventor based in Seoul, South Korea, has made significant contributions to the field of bio-sensor technology. With a total of 11 patents to his name, Rhim's innovative approach to monitoring post-translational modifications of proteins has garnered attention within the scientific community.

Latest Patents: Among his latest patents is a groundbreaking "System for monitoring post-translational modification of protein using bio-sensor with gap and manufacturing method for bio-sensor." This invention focuses on diagnosing diseases associated with specific proteins by measuring impedance in a sensor and calculating impedance changes in samples, offering a high-reliability solution for disease diagnosis. Additionally, Rhim has patented "Imidazolylalkylcarbonyl derivatives as calcium channel modulators and preparation method thereof," showcasing his expertise in developing novel compounds for disease treatment.

Career Highlights: Hyewhon Rhim is a key figure at the Korea Institute of Science and Technology, where he continues to drive innovation in the field of bio-sensors and protein monitoring. His dedication to research and development has positioned him as a respected authority in the scientific community, with a track record of successful patent applications that have paved the way for new advancements in medical technology.

Collaborations: Rhim's work at KIST has also involved collaborations with esteemed colleagues such as Ae Nim Pae and Seon Hee Seo. Together, they have contributed to groundbreaking research projects that have the potential to shape the future of bio-sensor technology and disease treatment.

Conclusion: In conclusion, Hyewhon Rhim's inventive spirit and pioneering work in bio-sensor technology highlight his commitment to driving innovation and making a lasting impact in the field of medical science. His patents stand as a testament to his ingenuity and dedication to advancing technology for the betterment of society.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…